Catheter-Related Bloodstream Infection Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities
Discover trends, market shifts, and competitive outlooks for the catheter-related bloodstream infection industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Catheter-Related Bloodstream Infection Market From 2025 To 2029?
In recent times, there has been a remarkable expansion in the market for catheter-related bloodstream infections. This market, currently valued at $1.53 billion in 2024, is predicted to escalate to $1.62 billion by 2025, with a compound annual growth rate (CAGR) of 6.2%. A myriad of factors contribute to this growth during the historic phase, including the escalating prevalence of chronic illnesses, heightened awareness and education, an increase in hospital-acquired infections, a burgeoning senior population, and the strengthening of infection control programs within hospital and healthcare environments.
The market size for catheter-related bloodstream infections is forecasted to experience robust expansion in the coming years, with projections indicating a growth to $2.05 billion in 2029 at a CAGR of 6.0%. This anticipated growth during the projected period can be ascribed to a surge in healthcare-related infections, a heightened focus on education and awareness, improved training programs on infection control methods, the development of the healthcare infrastructure, an increase in the aged population, and beneficial government policies and initiatives. Key innovations predicted to occur during this period include advancements in biomaterials, intelligent catheter technology, the creation of enhanced catheter lock solutions featuring superior antimicrobial traits, sterilization process developments for catheters, and the introduction of automated flushing systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp
What Are the Core Growth Drivers Propelling the Catheter-Related Bloodstream Infection Market Forward?
The growth of the market for catheter-related bloodstream infections is anticipated to be driven by the escalating occurrence of hospital-acquired infections. These are infections contracted by patients within healthcare settings while being treated for other medical conditions, often becoming apparent 48 hours or more after being admitted. The surge in hospital-acquired infections is due to a range of aspects such as antimicrobial resistance, inadequate measures to control infection, and patient vulnerability. A significant portion of hospital-acquired infections is owing to catheter-related bloodstream infections, attributable to their invasive characteristics and the probability for microbial colonization, which presents risks for patients with indwelling catheters. For example, as reported by the National Library of Medicine, a biomedical library based in the US, in January 2023, the global rate of healthcare-associated infection (HAI) was 0.14%, with an annual increase of 0.06%. Consequently, the escalating occurrence of hospital-acquired infections is poised to stimulate the growth of the market for catheter-related bloodstream infections.
What Segment Types Define the Catheter-Related Bloodstream Infection Market Structure?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Catheter-Related Bloodstream Infection Industry?
In the catheter-related bloodstream infection market, top businesses are creating unique catheter lock solutions aimed at strengthening preventative measures against infection and elevating patient outcomes. The catheter lock solution refers to a fluid used to prevent infections and ensure catheter openness after each use. For example, in November 2023, CorMedix Inc., a biopharmaceutical firm based in the US that focuses on the development and distribution of therapeutic products, was granted approval by the US Food and Drug Administration for their product, DefenCath (taurolidine and heparin). This solution is used in catheter locking for adult patients suffering from kidney failure who are receiving chronic hemodialysis through a central venous catheter (CVC). DefenCath, an anti-microbial and anti-fungal solution, is designed to decrease catheter-related bloodstream infections (CRBSIs) by merging heparin’s anticoagulant abilities with the broad antimicrobial capabilities of taurolidine.
View the full report here:
What Is the Definition of the Catheter-Related Bloodstream Infection Market?
Catheter-related bloodstream infection (CRBSI) is a type of infection that occurs when bacteria or fungi enter the bloodstream through a catheter, a tube inserted into a vein to deliver medications or nutrients. It is a serious healthcare-associated infection that can lead to sepsis and other complications. Prompt diagnosis and treatment are essential to prevent severe outcomes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
